Login / Signup

Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.

Stewart J TepperMessoud AshinaUwe ReuterJan Lewis BrandesDavid DoležilStephen D SilbersteinPaul WinnerFeng ZhangSunfa ChengDaniel D Mikol
Published in: Cephalalgia : an international journal of headache (2020)
This study is registered at ClinicalTrials.gov (NCT02174861).
Keyphrases
  • open label
  • clinical trial
  • randomized controlled trial
  • radiation therapy
  • study protocol